ECSP982436A - COMPOSITION - Google Patents

COMPOSITION

Info

Publication number
ECSP982436A
ECSP982436A ECSP982436A ECSP982436A EC SP982436 A ECSP982436 A EC SP982436A EC SP982436 A ECSP982436 A EC SP982436A EC SP982436 A ECSP982436 A EC SP982436A
Authority
EC
Ecuador
Prior art keywords
composition
pharmaceutically acceptable
sodium bicarbonate
acceptable excipient
capsule formulation
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Timothy James Grattan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982436 priority Critical patent/ECSP982436A/en
Publication of ECSP982436A publication Critical patent/ECSP982436A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe una formulación de comprimido o cápsula para tragar que contiene paracetamol, bicarbonato sódico y al menos un excipiente farmacéuticamente aceptable.A swallow tablet or capsule formulation is described that contains paracetamol, sodium bicarbonate and at least one pharmaceutically acceptable excipient.

ECSP982436 1998-03-03 1998-03-03 COMPOSITION ECSP982436A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982436 ECSP982436A (en) 1998-03-03 1998-03-03 COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982436 ECSP982436A (en) 1998-03-03 1998-03-03 COMPOSITION

Publications (1)

Publication Number Publication Date
ECSP982436A true ECSP982436A (en) 1999-01-05

Family

ID=42043358

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982436 ECSP982436A (en) 1998-03-03 1998-03-03 COMPOSITION

Country Status (1)

Country Link
EC (1) ECSP982436A (en)

Similar Documents

Publication Publication Date Title
MY119722A (en) Swallow tablet comprising paracetamol.
ID27504A (en) NEW ORAL FORMULATION
AR016481A1 (en) PHARMACEUTICAL PREPARATIONS THAT ARE ORALALLY DISINTEGRATED THAT CONTAIN SILDENAFILO
ES2161690T3 (en) PHARMACEUTICAL FORMULATIONS.
BR9912979B1 (en) orally administrable pharmaceutical composition, chewing tablet, capsule and use of chitosan.
AP1954A (en) Controlled release compositions comprising nimesulide.
CY1109636T1 (en) ORAL DOSAGE COMPOSITION
ES2182357T3 (en) NEW USE OF BUDESONIDE AND FORMOTEROL.
ES2157881T3 (en) PAROXETINE METHANOSULFONATE.
NO942834L (en) 1-Benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, preparation thereof, and pharmaceutical compositions containing them
BG103425A (en) Pharmaceutical composition
ES2176684T3 (en) NEW ASSOCIATIONS OF ACTIVE PRINCIPLES CONTAINING CLOPIDOGREL AND AN ANTHROMBOTIC.
DK0994710T3 (en) Pharmaceutical compositions for oral administration comprising a benzhydrylpiperazine and a cyclodextrin
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
SE9700885D0 (en) New pharmaceutical formulation
MY136059A (en) Swallow tablet comprising paracetamol
ATE258788T1 (en) TABLET
ATE304844T1 (en) ANTI-INFLAMMATORY PHARMACEUTICAL FORMULATIONS
BR0112847A (en) Use of a solid dosage form
AR023699A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INSULIN STABILIZER AND A PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION
BR0209155A (en) Pharmaceutical tablet having a high api content
FI963567A0 (en) The diclofenacs containing prolonged-release tablets
ECSP982436A (en) COMPOSITION
AR019331A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN INSULIN SENSITIZER AND AN INSULIN SECRETAGOG.
ES2191241T3 (en) PHARMACEUTICAL PREPARATIONS BY ORAL ROUTE THAT INCLUDE S- (3-HYDROXIPROPIL) -L-CISTEINE.